{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:47:29Z","timestamp":1759384049637,"version":"3.44.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009012","name":"Veterans Affairs San Diego Healthcare System","doi-asserted-by":"publisher","award":["10-92-035"],"award-info":[{"award-number":["10-92-035"]}],"id":[{"id":"10.13039\/100009012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI47745","AI36214","AI29164","AI43752","NS51132","AI077304","AI57167","AI69432","MH083552","MH62512","AI047745","DA12065","AI43638","AI38858","AI 064086","AI27670"],"award-info":[{"award-number":["AI47745","AI36214","AI29164","AI43752","NS51132","AI077304","AI57167","AI69432","MH083552","MH62512","AI047745","DA12065","AI43638","AI38858","AI 064086","AI27670"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.virol.2009.08.007","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T05:07:13Z","timestamp":1253164033000},"page":"243-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance"],"prefix":"10.1016","volume":"394","author":[{"given":"George K.","family":"Hightower","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott L.","family":"Letendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Cherner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya J.","family":"Wolfson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony C.","family":"Gamst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline C.","family":"Ignacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas D.","family":"Richman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davey M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virol.2009.08.007_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2006-956759","article-title":"Dementia and neurocognitive disorders due to HIV-1 infection","volume":"27","author":"Ances","year":"2007","journal-title":"Semin. Neurol."},{"issue":"17","key":"10.1016\/j.virol.2009.08.007_bib2","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1097\/00002030-200111230-00017","article-title":"Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy","volume":"15","author":"Antinori","year":"2001","journal-title":"Aids"},{"issue":"14","key":"10.1016\/j.virol.2009.08.007_bib3","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/00002030-200209270-00003","article-title":"Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients","volume":"16","author":"Antinori","year":"2002","journal-title":"Aids"},{"issue":"12","key":"10.1016\/j.virol.2009.08.007_bib4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1086\/498310","article-title":"Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma","volume":"41","author":"Antinori","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"18","key":"10.1016\/j.virol.2009.08.007_bib5","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.virol.2009.08.007_bib7","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1128\/JVI.76.21.11104-11112.2002","article-title":"Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults","volume":"76","author":"Barbour","year":"2002","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2009.08.007_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/514001","article-title":"Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage","volume":"175","author":"Brew","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"22","key":"10.1016\/j.virol.2009.08.007_bib9","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1128\/JVI.77.22.12105-12112.2003","article-title":"Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma","volume":"77","author":"Campbell","year":"2003","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2009.08.007_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1212\/01.WNL.0000158328.26897.0D","article-title":"Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine","volume":"64","author":"Cherner","year":"2005","journal-title":"Neurology"},{"issue":"Suppl. 3","key":"10.1016\/j.virol.2009.08.007_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/13550280500513762","article-title":"Neurologic consequences of hepatitis C and human immunodeficiency virus coinfection","volume":"11","author":"Clifford","year":"2005","journal-title":"J. Neurovirol."},{"issue":"2","key":"10.1016\/j.virol.2009.08.007_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/JVI.78.2.603-611.2004","article-title":"Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants","volume":"78","author":"Collins","year":"2004","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2009.08.007_bib13","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1128\/JVI.02712-06","article-title":"The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions","volume":"81","author":"Cong","year":"2007","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2009.08.007_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJM200102153440702","article-title":"Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia","volume":"344","author":"Deeks","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.virol.2009.08.007_bib15","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1097\/00002030-200109280-00027","article-title":"AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy","volume":"15","author":"Deutsch","year":"2001","journal-title":"Aids"},{"issue":"5","key":"10.1016\/j.virol.2009.08.007_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410420503","article-title":"Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group","volume":"42","author":"Ellis","year":"1997","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.virol.2009.08.007_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/13550280802132857","article-title":"Monocyte\/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies","volume":"14","author":"Fischer-Smith","year":"2008","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.virol.2009.08.007_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.qai.0000197077.64021.07","article-title":"Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy","volume":"41","author":"Giancola","year":"2006","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"8","key":"10.1016\/j.virol.2009.08.007_bib50","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1128\/jvi.70.8.5662-5664.1996","article-title":"Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase","volume":"70","author":"Goudsmit","year":"1996","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2009.08.007_bib19","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/JVI.72.5.3773-3778.1998","article-title":"Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro","volume":"72","author":"Harrigan","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2009.08.007_bib20","first-page":"1","article-title":"Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China","author":"Heaton","year":"2008","journal-title":"J. Neurovirol."},{"issue":"Pt. 1","key":"10.1016\/j.virol.2009.08.007_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1099\/0022-1317-83-1-93","article-title":"In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants","volume":"83","author":"Iglesias-Ussel","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"7","key":"10.1016\/j.virol.2009.08.007_bib22","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200305020-00001","article-title":"Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus","volume":"17","author":"Koelsch","year":"2003","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.virol.2009.08.007_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virol.2006.05.021","article-title":"Relative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V","volume":"353","author":"Koval","year":"2006","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2009.08.007_bib24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.20198","article-title":"Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders","volume":"56","author":"Letendre","year":"2004","journal-title":"Ann. Neurol."},{"issue":"Suppl. 3","key":"10.1016\/j.virol.2009.08.007_bib25","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/01.aids.0000192073.18691.ff","article-title":"The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease","volume":"19","author":"Letendre","year":"2005","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.virol.2009.08.007_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/519285","article-title":"Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV","volume":"196","author":"Letendre","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.virol.2009.08.007_bib53","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":"Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance","volume":"23","author":"Marra","year":"2009","journal-title":"Aids"},{"issue":"1\u20132","key":"10.1016\/j.virol.2009.08.007_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virusres.2007.12.021","article-title":"HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo","volume":"134","author":"Martinez-Picado","year":"2008","journal-title":"Virus Res."},{"issue":"1\u20132","key":"10.1016\/j.virol.2009.08.007_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.08.042","article-title":"HIV dementia: an evolving disease","volume":"157","author":"McArthur","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.virol.2009.08.007_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410420504","article-title":"Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain","volume":"42","author":"McArthur","year":"1997","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.virol.2009.08.007_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jviromet.2003.09.032","article-title":"Viral growth assay to evaluate the replicative capacity of HIV-1 isolates","volume":"115","author":"Nicastri","year":"2004","journal-title":"J. Virol. Methods"},{"issue":"4","key":"10.1016\/j.virol.2009.08.007_bib30","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1128\/JVI.02154-08","article-title":"In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine","volume":"83","author":"Paredes","year":"2009","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2009.08.007_bib31","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1128\/JVI.01620-06","article-title":"Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages","volume":"81","author":"Perez-Bercoff","year":"2007","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virol.2009.08.007_bib32","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/01.aids.0000186824.53359.62","article-title":"Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women","volume":"19","author":"Richardson","year":"2005","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.virol.2009.08.007_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617704101021","article-title":"Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons","volume":"10","author":"Rippeth","year":"2004","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"Suppl. 2","key":"10.1016\/j.virol.2009.08.007_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/13550280290101094","article-title":"The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"J. Neurovirol."},{"issue":"19","key":"10.1016\/j.virol.2009.08.007_bib51","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1128\/JVI.74.19.9306-9312.2000","article-title":"Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells","volume":"74","author":"Samri","year":"2000","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2009.08.007_bib52","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00002030-200004140-00004","article-title":"Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes","volume":"14","author":"Schmitt","year":"2000","journal-title":"Aids"},{"issue":"11","key":"10.1016\/j.virol.2009.08.007_bib35","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1212\/01.WNL.0000145763.68284.15","article-title":"Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia","volume":"63","author":"Sevigny","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.virol.2009.08.007_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1086\/519164","article-title":"Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission","volume":"196","author":"Smith","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virol.2009.08.007_bib37","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/508750","article-title":"Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure","volume":"194","author":"Spudich","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2009.08.007_bib38","unstructured":"Spitzer, 1995 Spitzer. Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders version IV 1995."},{"key":"10.1016\/j.virol.2009.08.007_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2307\/1907382","article-title":"Estimation of relationships for limited dependent variables","volume":"v26","author":"Tobin","year":"1958","journal-title":"Econometrica"},{"issue":"2","key":"10.1016\/j.virol.2009.08.007_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QAI.0b013e318042e1ee","article-title":"Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors","volume":"45","author":"Tozzi","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"11","key":"10.1016\/j.virol.2009.08.007_bib41","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/QAD.0b013e328220e71a","article-title":"HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people","volume":"21","author":"Vitiello","year":"2007","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.virol.2009.08.007_bib42","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.virol.2006.01.014","volume":"348","author":"Wang","year":"2006","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2009.08.007_bib43","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1128\/JCM.43.3.1395-1400.2005","article-title":"Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation","volume":"43","author":"Weber","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"10.1016\/j.virol.2009.08.007_bib45","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.46.11.3437-3446.2002","article-title":"Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity","volume":"46","author":"White","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.virol.2009.08.007_bib46","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/13803390490509565","article-title":"Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV","volume":"26","author":"Woods","year":"2004","journal-title":"J. Clin. Exp. Neuropsychol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682209004875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682209004875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:02:37Z","timestamp":1758585757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682209004875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0042682209004875"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2009.08.007","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2009.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}